[1]
Quilty, R. et al. 2019. Rituximab and Immune Molecule Modulation in Burkitt’s Lymphoma Cell Lines. University of Ottawa Journal of Medicine. 9, 1 (May 2019), 33–39. DOI:https://doi.org/10.18192/uojm.v9i1.4160.